News
Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...
A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
Novo Nordisk’s new weight-loss drug helped patients lose even more weight on average than its current Wegovy blockbuster ...
In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...
People started on a low dose of Amgen's long-acting experimental obesity drug MariTide lost as much weight as those given ...
Amgen's late-stage weight-loss drug MariTide is getting ready to enter the final stages of testing as the company enrolls its ...
COPENHAGEN (Reuters) -Drugmaker Novo Nordisk said on Monday it would halt its Wegovy weight-loss drug agreement with U.S.
Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while ...
Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing ...
A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few ...
Drugmakers are racing to develop the next wave of obesity and diabetes medications that they hope will be even more powerful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results